Neuropathology in Adults Intensive Care Unit Patients With COVID 19
NCT ID: NCT04453670
Last Updated: 2020-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7 participants
OBSERVATIONAL
2020-03-10
2020-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
NCT04401111
Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors
NCT04881266
Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19
NCT04388670
Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)
NCT04491214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Oversight: As per legal health authority requirement only patients with suspected or confirmed severe acute respiratory syndrome (SARS)- related to coronavirus 2 infection were admitted to the ICU. The department of pathology and forensic medicine is allowed by legal authority to perform autopsy of non-survivors from COVID-19 to inform the cause of death as per ministerial decree of July 12 2017 and March 28, 2020. In this context, of autopsy for medical purpose and public interest there is no requirement for institutional review board submission. However, consent from patients legal representative or closest relatives is required for autopsy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 non-survivors
ICU adults who died from severe COVID-19 and in whom autopsy could be performed
autopsy
autopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
autopsy
autopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to the ICU
* confirmed COVID-19
* died during ICU stay
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Versailles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Djillali Annane
Professor in intensive care medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
djillali annane
Role: STUDY_CHAIR
University Versailles SQY Unversité Paris Saclay
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Raymond Poincaré
Garches, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Obs2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.